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Abstract
Objective: The s allele of the 5-hydroxytryptamine transporter-linked promoter region (5-HTTLPR) polymorphism of
the serotonin transporter gene has been found to be associated with neuroticism-related traits, affective
temperaments and response to selective serotonin reuptake inhibitor (SSRI) treatment. The aim of the current study
was to develop a psychometric tool that could at least partially substitute for laboratory testing and could predict
the presence of the s allele.
Methods: The study included 138 women of Caucasian origin, mean 32.20 ± 1.02 years old. All subjects completed
the Hungarian standardised version of the Temperament Evaluation of the Memphis, Pisa, Paris, and San Diego
Autoquestionnaire (TEMPS-A) instrument and were genotyped for 5-HTTLPR using PCR. The statistical analysis
included the calculation of the Index of Discrimination (D), Discriminant Function Analysis, creation of scales on the
basis of the above and then item analysis and calculation of sensitivity and specificity.
Results: Four indices were eventually developed, but their psychometric properties were relatively poor and their
joint application did not improve the outcome.
Conclusions: We could not create a scale that predicts the 5-HTTLPR genotype with sufficient sensitivity and
specificity, therefore we could not substitute a psychometric scale for laboratory genetic testing in predicting
genotype, and also possibly affective disorder characterisation and treatment.
Background
The s allele of the 5-hydroxytryptamine transporter-linked
promoter region (5-HTTLPR) polymorphism of the sero-
tonin transporter gene has been shown to be significantly
associated with both unipolar, bipolar and subthreshold
forms of affective disorder [1-8] and also the neuroticism
trait [9-12], indicating a significant role of the polymorph-
ism in the background of affective phenomena and pathol-
ogy. In a previous paper we described that affective
temperaments composing the depressive superfactor (that
is, depressive, cyclothymic, anxious and irritable tempera-
ments also show a significant association with the s allele)
[13]. In a more recent paper, we attempted to compose a
scale of those items of the Temperament Evaluation of the
Memphis, Pisa, Paris, and San Diego Autoquestionnaire
(TEMPS-A) scale measuring affective temperaments that
differentiate most sensitively between subjects carrying
and not carrying the s allele, and we managed to derive a
scale consisting of nine items that was able to differentiate
between the two groups at a good level of significance and
also showed good internal consistency [14]. Since the s
allele is associated not only with neuroticism and tendency
to develop affective disorders in the face of adverse life
events, but also with less favourable response to selective
serotonin reuptake inhibitors (SSRIs) [15-19], we consid-
ered it of interest to develop a scale which could predict
presence of the s allele to a high accuracy and thus less
likely SSRI response. For this purpose a careful and
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ing and validating the scale.
In the present paper we attempted to delineate and
validate a scale based on the TEMPS-A questionnaire to
predict the presence of the 5-HTTLPR s allele scale
with a different and more rigorous approach.
Methods
Study participants
The study population included 138 psychiatrically healthy
unrelated Hungarian women of Caucasian origin. All par-
ticipants were aged between 18-64 years; the mean age of
our subjects was 32.20 ± 1.02 years. All subjects were
screened for neurological and psychiatric disorders using
the standardised Hungarian version of the MINI Interna-
tional Neuropsychiatric Interview [20]. Subjects with any
neurological and current or lifetime Diagnostic and Statis-
tical Manual of Mental Disorders, fourth edition (DSM-
IV) Axis I psychiatric disorders were excluded.
The study protocol was reviewed and approved by the
Scientific and Research Ethics Committee of the Scientific
Health Council of Hungary in charge of genetic experi-
mentation concerning human subjects. All subjects gave
written informed consent before participating in the study.
Methodology
All subjects completed the Hungarian standardised ver-
sion of the TEMPS-A questionnaire that measures affec-
tive temperaments on five scales, the depressive,
cyclothymic, irritable, anxious and hyperthymic tem-
peraments [14,21,22].
All subjects were genotyped for 5-HTTLPR by PCR.
PCR amplification of 5HTTLPR was performed on
genomic DNA extracted from buccal cells [23], and
5HTTLPR genotypes were identified as previously
reported [24].
Statistical analysis
All statistical analyses were carried out using Statistica
7.0 for Windows (Statsoft, Tulsa, OK, USA). In all cases
we analysed our data according to the additive model
(subjects with either of the three different genotypes: ss,
sl, ll), according to the dominant model (subjects carry-
ing the s allele and subjects not carrying the s allele),
and according to the recessive model (subjects carrying
the l allele vs subjects not carrying the l allele).
The first step included the calculation of the equiva-
lent of the degree of difficulty [25] as a measure of an
Index of Discrimination (D) in order to identify those
items from the TEMPS-A scale that best discriminate
groups. The D corresponds to the difference in the per-
centages in the responses given between two groups.
The second step included the development of the scales
with weighting the item responses; those with D above
15 were included in the scales with those with D above
20 weighted with a factor of 2, while those with D
below 20 were weighted with a factor of 1.
Discriminant function analysis was also used in order
to obtain two additional indices that could help in
separating groups. All the items with D above 15 were
included in this type of analysis.
Item analysis was performed, and the value of Cron-
bach’s a for each scale was calculated. The sensitivity
(Sn) and Specificity (Sp) were also calculated.
Results
In all, 19 (13.76%) subjects carried the ss genotype, 50
(36.23%) the ll and 69 (50%) sl genotype. A total of 88
subjects (63.77%) carried the s allele while 50 subjects
(36.23%) did not carry the s allele. The frequency of
the s allele in our sample was 38.77% which parallels
the results of earlier studies and is representative of the
Caucasian population [24]. The distribution of geno-
types in our study population followed the Hardy-Wein-
berg equilibrium (c
2 = 0.38934, P = 0.8231).
The various genotype groups (ss, sl and ll) did not dif-
fer in age (P > 0.05) and they also did not differ con-
cerning all the TEMPS-A subscales (Wilk’s l = 0.8833,
F = 1.63, df = 10,262, P = 0.0980). However, post hoc
comparisons indicated a significant difference in case of
Table 1 Descriptive statistics of the various study groups
Dominant model: presence vs absence of s allele Recessive model: presence vs absence of l allele
ss and sl (n = 88) ll (n = 50) sl and ll (n = 119) ss (n = 19) sl (n = 69)
Mean ± SD Min Max Mean ± SD Min Max Mean ± SD Min Max Mean ± SD Min Max Mean ± SD Min Max
Depressive 7.30 ± 3.18 2 16 5.98 ± 2.40 2 12 6.77 ± 3.05 2 16 7.11 ± 2.56 3 11 7.35 ± 3.35 2 16
Cyclothymic 6.23 ± 4.10 0 17 4.34 ± 3.01 0 11 5.62 ± 3.92 0 17 5.05 ± 3.34 0 10 6.55 ± 4.24 0 17
Hyperthymic 10.06 ± 3.67 1 20 10.72 ± 4.53 2 22 10.36 ± 4.09 1 22 9.89 ± 3.43 4 15 10.10 ± 3.75 1 20
Irritable 4.59 ± 3.53 0 15 3.30 ± 2.72 0 11 4.21 ± 3.41 0 15 3.58 ± 2.63 0 9 4.87 ± 3.71 0 15
Anxious 8.20 ± 5.25 0 19 5.94 ± 4.48 0 18 7.22 ± 5.10 0 19 8.42 ± 4.99 0 18 8.14 ± 5.35 0 19
ll scale 5.49 ± 2.85 0 11 3.24 ± 2.33 0 10 4.61 ± 2.89 0 11 5.05 ± 2.88 0 11 5.61 ± 2.85 0 11
ss scale 5.20 ± 2.46 1 11 4.12 ± 2.16 0 9 4.50 ± 2.25 0 11 6.74 ± 2.54 2 10 6.74 ± 2.54 2 10
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scales. When considering the presence or absence of the
s allele (ss and sl combined vs the ll) then the difference
concerning the TEMPS-A subscales was significant
(Wilk’s l = 0.91, F = 2.40, df = 5,132, P = 0.0403) and
concerned all individual subscales except the Hyperthy-
mic (Depressive, Anxious, Cyclothymic, Irritable). The
descriptive statistics are shown in Table 1.
The results from the calculation of D are shown in
Tables 2 and 3. The resulting scale from the application
of weighting on the selected items is shown in Table 4.
Cronbach’s a was 0.48 for the ss and 0.66 for the ll
scale. All items were more or less equal and omission of
any of them did not alter the a value significantly.
The calculation of sensitivity (Sn) and specificity (Sp)
at various cut-off levels for the two scales is shown in
Table 5. The discriminant function analysis results are
shown in Table 6. Both Sn and Sp as well as the discri-
minant function analysis results are poor and can not
lead to the identification of cases. The combined use of
these indices led to poor results as well since no case
Table 2 Discrimination index (D) between the groups
according to the dominant model (ss + sl vs ll)
concerning the Temperament Evaluation of the Memphis,
Pisa, Paris, and San Diego Autoquestionnaire (TEMPS-A)
items
Dominant model (subjects carrying the s allele vs subjects not
carrying the s allele)
TEMPS-A item ss or sl (N = 88) ll (N = 50) D
107A 51.14 28.00 23.14
17D 59.09 36.00 23.09
69I 45.45 26.00 19.45
7D 46.59 28.00 18.59
39C 36.36 20.00 16.36
94A 34.09 18.00 16.09
68I 31.82 16.00 15.82
29C 29.55 14.00 15.55
92A 53.41 38.00 15.41
27C 51.14 36.00 15.14
15D 38.64 24.00 14.64
99A 38.64 24.00 14.64
110A 52.27 38.00 14.27
100A 18.18 4.00 14.18
86A 34.09 20.00 14.09
89A 34.09 20.00 14.09
105A 50.00 36.00 14.00
52H 50.00 36.00 14.00
34C 31.82 18.00 13.82
35C 55.68 42.00 13.68
87A 29.55 16.00 13.55
4D 19.32 6.00 13.32
42C 19.32 6.00 13.32
64I 27.27 14.00 13.27
22C 43.18 30.00 13.18
73I 28.41 16.00 12.41
88A 34.09 22.00 12.09
24C 13.64 2.00 11.64
12D 29.55 18.00 11.55
23C 37.50 26.00 11.50
77I 27.27 16.00 11.27
90A 35.23 24.00 11.23
71I 20.45 10.00 10.45
33C 20.45 10.00 10.45
40C 36.36 26.00 10.36
66I 18.18 8.00 10.18
21D 26.14 16.00 10.14
The capital letter after the item number denotes the TEMPS-A subscale: A =
anxious, D = depressive, C = cyclothymic or I = irritable.
Table 3 Discrimination index (D) between the groups
according to the recessive model (ss vs sl + ll) concerning
the Temperament Evaluation of the Memphis, Pisa, Paris,
and San Diego Autoquestionnaire (TEMPS-A) items
Recessive model (subjects carrying the l allele vs subjects not
carrying the l allele)
TEMPS-A item ss (N = 19) sl or ll (N = 119) D
98A 63.16 33.61 29.54
57H 63.16 42.02 21.14
55H 84.21 63.87 20.34
107A 57.89 40.34 17.56
71I 31.58 14.29 17.29
103A 63.16 47.06 16.10
89A 42.11 26.89 15.21
105A 57.89 42.86 15.04
91A 36.84 21.85 14.99
87A 36.84 22.69 14.15
110A 57.89 45.38 12.52
79I 21.05 9.24 11.81
33C 26.32 15.13 11.19
40C 42.11 31.09 11.01
16D 89.47 78.99 10.48
99A 42.11 31.93 10.17
15D 42.11 31.93 10.17
The capital letter after the item number denotes the TEMPS-A subscale: A =
anxious, D = depressive, C = cyclothymic or I = irritable.
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allele category.
All scales and indices correlated moderately but signif-
icantly with all TEMPS-A subscales (Table 7).
Discussion
In the present work we attempted to extract a scale
from the TEMPS-A questionnaire that would predict
the presence of the s allele of the 5-HTTLPR with satis-
factory sensitivity and specificity. However, although
several items discriminate between the different geno-
type groups to a high degree, no scale compiling these
items showed high sensitivity and specificity with
respect to the presence of the s allele. Even the combi-
nation of the scales that were derived cannot improve
the poor classification outcome.
To understand the nature of psychometric disorders and
to make more efficient treatment possible, we must not
only view these disorders as complex entities in the con-
text of their social, cultural, neurochemical and genetic
determinants, but we should also be able to decompose
psychiatric disorders into smaller and better characterisa-
ble components. The concept of endophenotypes was
introduced to aim at identifying and characterising small,
atomic phenomena that correspond to an accurately char-
acterisable biochemical process or marker, such as a
genetic polymorphism, and which is at the same time
highly relevant in the manifestation of psychological phe-
nomena or psychiatric disorders. There is an expanding
effort to identify traits and temperaments related to the
development of psychiatric illnesses and associate them
with genetic factors. Studies have attempted to link psy-
chological traits as measured by psychometric scales with
a given polymorphism. Our approach in this case was dif-
ferent: based on an association we had already described
between the 5-HTTLPR s allele and several affective tem-
peraments measured by TEMPS-A [13,26], we aimed to
construct a scale which would show a high ability to pre-
dict 5-HTTLPR genotype.
In a previous paper we attempted to solve the task of
delineating a psychometric scale to predict presence of
the s allele by selecting the items which differentiated
between the different genotype groups using analysis of
variance (ANOVA) and performing a subsequent item
analysis [14]. In the current paper, however, we used a
more rigorous statistical approach in selecting the items
differentiating between the different genotype groups
and calculated also sensitivity and specificity. As a result,
Table 4 Scale resulting from the application of weighting on the selected items of the TEMPS-A/5-hydroxytryptamine
(5-HT) s allele subscale
Item Criteria Scoring
7D I have always blamed myself for what others might consider no big deal True = 1, False = 0
17D I would rather work for someone else than be the boss True = 1, False = 0
27C I often blow up at people and then feel guilty about it True = 1, False = 0
29C My mood often changes for no reason True = 1, False = 0
39C I am the kind of person who can be sad and happy at the same time True = 1, False = 0
55H I love to be with a lot of people True = 1, False = 0
57H I am known to be generous, and spend a lot of money on other people True = 1, False = 0
68I I often feel on edge True = 1, False = 0
69I I often feel wound up True = 1, False = 0
71I I often get so mad that I will just trash everything True = 1, False = 0
89A Many people have told me not to worry so much True = 1, False = 0
92A I often feel jittery inside True = 1, False = 0
94A I often have an upset stomach True = 1, False = 0
98A When someone is late coming home, I fear they have had an accident True = 1, False = 0
103A I am, by nature, a very cautious person True = 1, False = 0
105A I easily get headaches when stressed True = 1, False = 0
107A I’m an insecure person True = 1, False = 0
Index 1 (ss subscale): 2 × item 55 + 2 × item 57 + item 71 + item 89 + 2 × item 98 + item 103 + item 105 + item 107. Interpretation: score >6, highly likely for
being an SS.
Index 2 (ll subscale): 2 × item 107 + 2 × item 17 + item 69 + item 7 + item 39 + item 94 + item 68 + item 29 + item 92 + item 27. Interpretation: index 2: score
>3, highly unlikely for being an SS.
Index 3: If 1.19 × item 55 + 0.77 × item 57 + 0.94 × item 71 + 0.14 × item 89 + 1.14 × item 98 + 0.36 × item 103 - 0.02 × item 105 + 0.53 × item 107 - 4.38 <0
then it is highly unlikely to be an SS.
Index 4: If 0.09 × item 7 + 0.89 × item 17 + 0.34 × item 27 + 0.40 × item 29 + 0.79 × item 39 + 0.39 × item 68 + 0.26 × item 69 + 0.09 × item 92 + 0.26 × item
94 + 0.68 × item 107 - 0.91 <0 then it is highly likely to be either an SS or SL.
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sence of the s allele with adequate accuracy.
The role of genetic factors in the background of per-
sonality, vulnerability and consequently psychiatric dis-
orders has gained more recognition and wider
acceptance in modern times. It is well accepted that the
5 - H T T L P Rsa l l e l eh a sap r o f o u n dr o l ei nd e t e r m i n i n g
the emergence of neuroticism-related personality traits
[9-12,27] and psychiatric disorders as well [1,2,4]. It has
also been suggested and described in several studies that
t h ep r e s e n c eo ft h esa l l e l en o to n l ym a k e so n em o r e
likely to possess personality traits which are associated
with psychiatric diseases, especially anxiety and affective
disorders, but it also makes a less favourable response
to SSRI antidepressants more likely [15-17,28-31].
Understanding the underlying biological and personality
factors profoundly shapes and reorganises how we view
psychiatric disorders today and how they will be classi-
fied in the future. Also, these factors should be taken
into consideration when selecting the appropriate treat-
ment. Although genetic testing is an available and
affordable procedure nowadays, it is not widely used
due to several reasons including ethical factors. More-
over, the presence of a given polymorphic allele does
not predict the manifestation of a given disorder, only
indicates an increased risk. Similar is the case for drug
response associated with genetic factors. Therefore a
psychometric scale, which is short and easy to adminis-
ter, and is able to predict presence of the genotype asso-
ciated with certain personality factors, psychiatric
disorders or response to drugs with a great specificity
and sensitivity would be a useful tool not only in
research but also in everyday psychiatric practice. In our
study, however, we failed to develop such a scale, which
indicates that as yet we have no accurate and useful psy-
chometric tools that can substitute for biochemical
laboratory testing. However, we report these scales in
the current study in order to serve as a guide for future
research and as they give a gross impression of the psy-
chometric features associated with each genetic
category.
In interpreting our results and drawing our conclu-
sions, several limiting factors must be taken into consid-
eration. First of all, our sample was relatively small;
studies using larger samples would detect minor differ-
ences to a greater accuracy. Also, our sample consisted
entirely of women. Further studies are needed to investi-
gate the possibility of extracting a psychometric scale for
predicting the s allele in men and in a mixed-gender
general study population.
Conclusions
Genetic polymorphisms influence not only the emer-
gence of psychiatric diseases but also the pharmacother-
apeutic response of these disorders to treatment.
Although genetic polymorphisms only mildly contribute
to such phenotypical alterations, they may be taken into
account when selecting a pharmacological agent. A scale
closely related to a given polymorphism may thus be a
useful clinical tool, however, the development of such a
scale needs further research.
Table 5 Sensitivity and specificity of the two scales in
discriminating between subjects carrying and not
carrying the s allele
Score level TP TN FP FN Sensitivity Specificity
ss scale (subjects carrying the l allele vs subjects not carrying the l
allele):
4/5 15 62 57 4 78.95 52.10
5/6 13 81 38 6 68.42 68.07
5/6 13 81 38 6 68.42 68.07
6/7 11 97 22 8 57.89 81.51
ll scale (subjects carrying the s allele vs subjects not carrying the s
allele):
3/4 18 24 64 32 94.74 20.17
4/5 12 37 51 38 63.16 31.09
5/6 7 48 40 43 36.84 40.34
The ss scale discriminates between ss and combined sl and ll carriers
(subjects carrying vs subjects not carrying the l allele; recessive model). The ll
scale discriminates between ll and combined ss and sl carriers (subjects
carrying the s allele vs subjects not carrying the s allele; dominant model).
FN = false negative; FP = false positive; TN = true negative; TP = true positive.
Table 6 Discriminant function analysis and development
of the discriminating functions
ss scale ll scale
Correct (%) sl or ll ss Correct (%) sl or ss ll
ss 15.79 3 16 ll 56 28 22
sl or ll 99.16 1 118 ss or sl 85.23 13 75
Total 87.68 4 134 Total 74.64 41 97
The ss scale discriminates between ss and combined sl and ll carriers
(recessive model). The ll scale discriminates between ll and combined ss and
sl carriers (dominant model).
Function for ll scale: 0.09 × item 7 + 0.89 × item 17 + 0.34 × item 27 + 0.40 ×
item 29 + 0.79 × item 39 + 0.39 × item 68 + 0.26 × item 69 + 0.09 × item 92 +
0.26 × item 94 + 0.68 × item 107 - 0.91 <0 then it is either an ss or sl genotype.
Function for ss scale: 1.19 × item 55 + 0.77 × item 57 + 0.94 × item 71 + 0.14 ×
item 89 + 1.14 × item 98 + 0.36 × item 103 - 0.02 × item 105 + 0.53 × item 107
- 4.38 <0 then it is NOT an ss genotype.
Table 7 Correlation matrix among the developed scales
(ll subscale and ss subscale) and the TEMPS-A subscales
ll subscale ss subscale Index 3 Index 4
TEMPS-A Depressive 0.64 0.38 0.27 0.57
TEMPS-A Cyclothymic 0.65 0.41 0.40 0.64
TEMPS-A Hyperthymic -0.17 0.18 0.27 -0.17
TEMPS-A Irritable 0.48 0.34 0.39 0.46
TEMPS-A Anxious 0.71 0.66 0.53 0.58
All values are significant at P < 0.05.
Gonda et al. Annals of General Psychiatry 2010, 9:21
http://www.annals-general-psychiatry.com/content/9/1/21
Page 5 of 7Acknowledgements
These studies were supported by the Sixth Framework Programme of the
EU, LSHM-CT-2004-503474.
Author details
1Department of Pharmacodynamics, Semmelweis University, Faculty of
Medicine, Budapest, Hungary.
2Department of Clinical and Theoretical Mental
Health, Semmelweis University, Faculty of Medicine, Budapest, Hungary.
3Third Department of Psychiatry, Aristotle University, University Hospital
AHEPA, Thessaloniki, Greece.
4Institute of Forensic Medicine, Semmelweis
University, Faculty of Medicine, Budapest, Hungary.
5Department of
Psychiatry, University of California at San Diego, La Jolla, CA, USA.
Authors’ contributions
XG conceived the study, gathered and managed the data, performed the
genetic analysis, participated in the statistical analysis and wrote the paper.
KNF conceived the study, carried out the literature search and analysis and
participated in writing the paper. ZR participated in analysing the data and
writing the paper. AL participated in the genetic and statistical analysis. HSA
participated in designing the study, analysing the data and writing the
paper. GB participated in designing the study, analysing the data and
writing the paper. All authors read and approved the final
manuscript.
Competing interests
The authors declare that they have no competing interests.
Received: 24 February 2010 Accepted: 7 May 2010
Published: 7 May 2010
References
1. Bellivier F, Henry C, Szoke A, Schurhoff F, Nosten-Bertrand M, Feingold J,
Launay JM, Leboyer M, Laplanche JL: Serotonin transporter gene
polymorphisms in patients with unipolar or bipolar depression. Neurosci
Lett 1998, 255:143-146.
2. Bellivier F, Leroux M, Henry C, Rayah F, Rouillon F, Laplanche JL, Leboyer M:
Serotonin transporter gene polymorphism influences age at onset in
patients with bipolar affective disorder. Neurosci Lett 2002, 334:17-20.
3. Brieger P, Roettig S, Ehrt U, Wenzel A, Bloink R, Marneros A: TEMPS-a scale
in ‘mixed’ and ‘pure’ manic episodes: new data and methodological
considerations on the relevance of joint anxious-depressive
temperament traits. J Affect Disord 2003, 73:99-104.
4. Collier DA, Stöber G, Li T, Heils A, Catalano M, Di Bella D, Arranz MJ,
Murray RM, Vallada HP, Bengel D, Müller CR, Roberts GW, Smeraldi E,
Kirov G, Sham P, Lesch KP: A novel functional polymorphism within the
promoter of the serotonin transporter gene: possible role in
susceptibility to affective disorders. Mol Psychiatry 1996, 1:453-460.
5. Kendler KS, Gatz M, Gardner CO, Pedersen NL: Personality and major
depression: a Swedish longitudinal, population-based twin study. Arch
Gen Psychiatry 2006, 63:1113-1120.
6. Gonda X, Juhasz G, Laszik A, Rihmer Z, Bagdy G: Subthreshold depression
is linked to the functional polymorphism of the 5HT transporter gene. J
Affect Disord 2005, 87:291-297.
7. Levinson DF: The genetics of depression: a review. Biol Psychiatry 2006,
60:84-92.
8. Lotrich FE, Pollock BG: Meta-analysis of serotonin transporter
polymorphisms and affective disorders. Psychiatr Genet 2004, 14:121-129.
9. Katsuragi S, Kunugi H, Sano A, Tsutsumi T, Isogawa K, Nanko S, Akiyoshi J:
Association between serotonin transporter gene polymorphism and
anxiety-related traits. Biol Psychiatry 1999, 45:368-370.
10. Lesch KP, Bengel D, Heils A, Sabol SZ, Greenberg BD, Petri S, Benjamin J,
Muller CR, Hamer DH, Murphy DL: Association of anxiety-related traits
with a polymorphism in the serotonin transporter gene regulatory
region. Science 1996, 274:1527-1531.
11. Melke J, Landen M, Baghei F, Rosmond R, Holm G, Bjorntorp P, Westberg L,
Hellstrand M, Eriksson E: Serotonin transporter gene polymorphisms are
associated with anxiety-related personality traits in women. Am J Med
Genet 2001, 105:458-463.
12. Sen S, Burmeister M, Ghosh D: Meta-analysis of the association between a
serotonin transporter promoter polymorphism (5-HTTLPR) and anxiety-
related personality traits. Am J Med Genet B Neuropsychiatr Genet 2004,
127:85-89.
13. Gonda X, Rihmer Z, Zsombok T, Bagdy G, Akiskal KK, Akiskal HS: The
5HTTLPR polymorphism of the serotonin transporter gene is associated
with affective temperaments as measured by TEMPS-A. J Affect Disord
2006, 91:125-131.
14. Rózsa S, Rihmer Z, Gonda X, Szili I, Rihmer A, Ko N, Németh A, Pestality P,
Bagdy G, Alhassoon O, Akiskal KK, Akiskal HS: A study of affective
temperaments in Hungary: internal consistency and concurrent validity
of the TEMPS-A against the TCI and NEO-PI-R. J Affect Disord 2008,
106:45-53.
15. Murphy GM Jr, Hollander SB, Rodrigues HE, Kremer C, Schatzberg AF:
Effects of the serotonin transporter gene promoter polymorphism on
mirtazapine and paroxetine efficacy and adverse events in geriatric
major depression. Arch Gen Psychiatry 2004, 61:1163-1169.
16. Pollock BG, Ferrell RE, Mulsant BH, Mazumdar S, Miller M, Sweet RA, Davis S,
Kirshner MA, Houck PR, Stack JA, Reynolds CF, Kupfer DJ: Allelic variation in
the serotonin transporter promoter affects onset of paroxetine
treatment response in late-life depression. Neuropsychopharmacology
2000, 23:587-590.
17. Serretti A, Kato M, De Ronchi D, Kinoshita T: Meta-analysis of serotonin
transporter gene promoter polymorphism (5-HTTLPR) association with
selective serotonin reuptake inhibitor efficacy in depressed patients. Mol
Psychiatry 2007, 12:247-257.
18. Smeraldi E, Zanardi R, Benedetti F, Di Bella D, Perez J, Catalano M:
Polymorphism within the promoter of the serotonin transporter gene
and antidepressant efficacy of fluvoxamine. Mol Psychiatry 1998,
3:508-511.
19. Zanardi R, Benedetti F, Di Bella D, Catalano M, Smeraldi E: Efficacy of
paroxetine in depression is influenced by a functional polymorphism
within the promoter of the serotonin transporter gene. J Clin
Psychopharmacol 2000, 20:105-107.
20. Balazs J, Bitter I, Hideg K, Vitrai J: A MINI és a MINI Plusz kérdõív magyar
nyelvû változatának kidolgozása. (Development of the Hungarian
version of the M.I.N.I. and M.I.N.I. Plus questionnaires.). Psychiatria
Hungarica 1998, 13:160-168.
21. Rozsa S, Rihmer A, Ko N, Gonda X, Szili I, Szadoczky E, Pestality P, Rihmer Z:
Az affektív temperamentum: a TEMPS-A kérdõívvel serzett hazai
tapasztalatok. Psychiatria Hungarica 2006, 21:147-160.
22. Akiskal HS, Akiskal KK: TEMPS: Temperament Evaluation of Memphis, Pisa,
Paris and San Diego (Special Issue). J Affect Disord 2005, 85:1-242.
23. Walsh PS, Metzger DA, Higuchi R: Chelex 100 as a medium for simple
extraction of DNA for PCR-based typing from forensic material.
Biotechniques 1991, 10:506-513.
24. Heils A, Teufel A, Petri S, Stober G, Riederer P, Bengel D, Lesch KP: Allelic
variation of human serotonin transporter gene expression. J Neurochem
1996, 66:2621-2624.
25. Anastasi A: Psychological Testing New York, USA: Macmillan Publishing
Company, 6 1988.
26. Gonda X, Fountoulakis KN, Rihmer Z, Lazary J, Laszik A, Akiskal KK,
Akiskal HS, Bagdy G: Towards a genetically validated new affective
temperament scale: a delineation of the temperament ‘phenotype’ of 5-
HTTLPR using the TEMPS-A. J Affect Disord 2009, 112:19-29.
27. Mazzanti CM, Lappalainen J, Long JC, Bengel D, Naukkarinen H, Eggert M,
Virkkunen M, Linnoila M, Goldman D: Role of the serotonin transporter
promoter polymorphism in anxiety-related traits. Arch Gen Psychiatry
1998, 55:936-940.
28. Smits KM, Smits LJ, Peeters FP, Schouten JS, Janssen RG, Smeets HJ, van
Os J, Prins MH: The influence of 5-HTTLPR and STin2 polymorphisms in
the serotonin transporter gene on treatment effect of selective
serotonin reuptake inhibitors in depressive patients. Psychiatr Genet 2008,
18:184-190.
Gonda et al. Annals of General Psychiatry 2010, 9:21
http://www.annals-general-psychiatry.com/content/9/1/21
Page 6 of 729. Kesebir S, Vahip S, Akdeniz F, Yuncu Z, Alkan M, Akiskal H: Affective
temperaments as measured by TEMPS-A in patients with bipolar I
disorder and their first-degree relatives: a controlled study. J Affect Disord
2005, 85:127-133.
30. Lee R, Coccaro E: The neuropsychopharmacology of criminality and
aggression. Can J Psychiatry 2001, 46:35-44.
31. Lesch KP, Gutknecht L: Pharmacogenetics of the serotonin transporter.
Prog Neuropsychopharmacol Biol Psychiatry 2005, 29:1062-1073.
doi:10.1186/1744-859X-9-21
Cite this article as: Gonda et al.: How possible is the development of an
operational psychometric method to assess the presence of the 5-
HTTLPR s allele? Equivocal preliminary findings. Annals of General
Psychiatry 2010 9:21.
Submit your next manuscript to BioMed Central
and take full advantage of: 
• Convenient online submission
• Thorough peer review
• No space constraints or color ﬁgure charges
• Immediate publication on acceptance
• Inclusion in PubMed, CAS, Scopus and Google Scholar
• Research which is freely available for redistribution
Submit your manuscript at 
www.biomedcentral.com/submit
Gonda et al. Annals of General Psychiatry 2010, 9:21
http://www.annals-general-psychiatry.com/content/9/1/21
Page 7 of 7